Evotec SE (EVO) EBITDA (2009 - 2025)
Evotec SE (EVO) posted EBITDA of $67514.5 for Q4 2025, up 229.77% sequentially from -$52025.3 in Q3 2025, and up 121.69% YoY from $30455.0 in Q4 2024.
Evotec SE (EVO) EBITDA (2009 - 2025) Analysis & Trends
Evotec SE has reported EBITDA for 9 years, with the latest figure at $67514.5 in Q4 2025.
- Quarterly EBITDA rose 121.69% year-over-year to $67514.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16849.1 (down 75.46% YoY) and the FY2025 annual result came in at $61927.1, up 156.42% from the prior year.
- EBITDA grew to $67514.5 in Q4 2025 per EVO's latest filing, from -$52025.3 in the prior quarter.
- Over five years, EBITDA peaked at $80176.3 in Q4 2021 and troughed at -$52025.3 in Q3 2025.
- A 5-year average of $17042.0 and a median of $20918.2 in 2021 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2025: EBITDA slumped 882.27% in 2023, then jumped 121.69% in 2025.
- Over 5 years, EBITDA stood at $80176.3 in 2021, then slumped by 43.25% to $45503.0 in 2022, then advanced by 18.73% to $54024.0 in 2023, then plunged by 43.63% to $30455.0 in 2024, then soared by 121.69% to $67514.5 in 2025.
- According to Business Quant data, EBITDA over the past three periods registered $67514.5, -$52025.3, and $30455.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Evotec SE | 689.00 Mn | 688.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67,514.52 |
| Sep 30, 2025 | -52,025.29 |
| Dec 31, 2024 | 30,454.97 |
| Sep 30, 2024 | -29,095.13 |
| Dec 31, 2023 | 54,024.02 |
| Sep 30, 2023 | 13,266.65 |
| Jun 30, 2023 | -39,514.89 |
| Dec 31, 2022 | 45,503.03 |
| Sep 30, 2022 | 13,640.94 |
| Jun 30, 2022 | -4,022.80 |
| Mar 31, 2022 | 21,169.53 |
| Dec 31, 2021 | 80,176.35 |
| Sep 30, 2021 | 20,918.20 |
| Jun 30, 2021 | 8,162.55 |
| Mar 31, 2021 | 25,457.61 |
| Dec 31, 2020 | 127,123.14 |
| Sep 30, 2020 | 21,663.16 |
| Dec 31, 2019 | 69.41 Mn |
| Sep 30, 2010 | 867.74 |
| Jun 30, 2010 | 2,315.10 |